Suppression of prolactin secretion by benzodiazepines in vivo - PubMed

• PMID: 6979001
• DOI: 10.1159/000123330

Suppression of prolactin secretion by benzodiazepines in vivo

L Grandison. Neuroendocrinology. 1982.

Abstract

Administration of benzodiazepines to male or female rats was observed to inhibit prolactin release. Basal secretion of prolactin was only slightly suppressed with the highest dose of benzodiazepines; however, the rise in prolactin release following a stimulus was prevented even at low doses (0.1-1 mg/kg). The benzodiazepine diazepam blocked stress-induced prolactin release and, when given during the critical period of proestrus, the proestrus surge of prolactin. Diazepam administration also blunted the release of prolactin induced by dopaminergic receptor blockade following haloperidol, or by serotonergic receptor activation produced by fluoxetine, a serotonergic reuptake inhibitor plus 5-hydroxytryptophan, a serotonin precursor. Inhibition of prolactin release by benzodiazepine was dose related, and inhibition was still evident after repeated diazepam injection. The potency of three benzodiazepine analogues to inhibit prolactin release correlated with their potency to displace radiolabeled diazepam binding from brain membrane fractions or to induce other biological responses (clonazepam greater than diazepam greater than chlordiazepoxide). These actions of benzodiazepines on prolactin release are similar to those reported for gamma-aminobutyric acid (GABA). The hypothesis of a benzodiazepine GABA receptor complex suggests that GABA may be involved in these in vivo actions of diazepam.

Similar articles

• Actions of benzodiazepines on the neuroendocrine system.

  Grandison L. Grandison L. Neuropharmacology. 1983 Dec;22(12B):1505-10. doi: 10.1016/0028-3908(83)90119-3. Neuropharmacology. 1983. PMID: 6322044 Review.

• Effect of some benzodiazepines on the secretion of thyrotropic hormone and prolactin under conditions of experimental stress.

  Boyadjieva N, Ovtcharov R. Boyadjieva N, et al. Acta Physiol Pharmacol Bulg. 1987;13(2):18-21. Acta Physiol Pharmacol Bulg. 1987. PMID: 2890258

• Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.

  Bero LA, Kuhn CM. Bero LA, et al. J Pharmacol Exp Ther. 1987 Mar;240(3):825-30. J Pharmacol Exp Ther. 1987. PMID: 3031276

• Role of oxytocin on prolactin secretion during proestrus and in different physiological or pharmacological paradigms.

  Johnston CA, Negro-Vilar A. Johnston CA, et al. Endocrinology. 1988 Jan;122(1):341-50. doi: 10.1210/endo-122-1-341. Endocrinology. 1988. PMID: 3335212

• [Neuroendocrine effects of benzodiazepines].

  Humbert T. Humbert T. Ann Med Psychol (Paris). 1994 Mar;152(3):161-71. Ann Med Psychol (Paris). 1994. PMID: 8085710 Review. French.

Cited by

• Benzodiazepines and anterior pituitary function.

  Arvat E, Giordano R, Grottoli S, Ghigo E. Arvat E, et al. J Endocrinol Invest. 2002 Sep;25(8):735-47. doi: 10.1007/BF03345110. J Endocrinol Invest. 2002. PMID: 12240908 Review.

• Effects of chronic alprazolam treatment on plasma concentrations of glucocorticoids, thyroid hormones, and testosterone in cardiomyopathic hamsters.

  Ottenweller JE, Tapp WN, Natelson BH. Ottenweller JE, et al. Psychopharmacology (Berl). 1989;98(3):369-71. doi: 10.1007/BF00451689. Psychopharmacology (Berl). 1989. PMID: 2501814

• The stress-induced reduction in monoamine oxidase (MAO) A activity is reversed by benzodiazepines: role of peripheral benzodiazepine receptors.

  Armando I, Lemoine AP, Segura ET, Barontini MB. Armando I, et al. Cell Mol Neurobiol. 1993 Dec;13(6):593-600. doi: 10.1007/BF00711559. Cell Mol Neurobiol. 1993. PMID: 8194078

• Chlordiazepoxide attenuates response suppression induced by corticotropin-releasing factor in the conflict test.

  Britton KT, Morgan J, Rivier J, Vale W, Koob GF. Britton KT, et al. Psychopharmacology (Berl). 1985;86(1-2):170-4. doi: 10.1007/BF00431704. Psychopharmacology (Berl). 1985. PMID: 3927353

• Comparison between the interaction of steroids with [35S]TBPS binding to cerebral cortical and to pituitary membranes: correlation with inhibition of prolactin release.

  Vincens M, Shu C, Fortin M, Philibert D, Gaillard-Moguilewsky M. Vincens M, et al. Naunyn Schmiedebergs Arch Pharmacol. 1992 Nov;346(5):523-6. doi: 10.1007/BF00169007. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1335125

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • S. Karger AG, Basel, Switzerland